{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:23:29Z","timestamp":1791872609780,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Headache is among the most common comorbidities in epilepsy. This study examined the distribution of different primary headache disorders in a large cohort of patients with diagnosed epilepsy. Headache types were analysed with regard to gender, type of epilepsy and antiepileptic drugs (AEDs).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this prospective single-centre study, 500 patients with epilepsy (250 female, mean age: 45.52\u2009\u00b1\u200917.26\u00a0years) were evaluated with regards to primary headache types using a validated German headache questionnaire categorizing for migraine (MIG), tension-type headache (TTH) or trigeminal autonomic cephalalgias (TAC), their combinations and unclassifiable headache. Data regarding type of epilepsy, seizure-associated headache, AED treatment and seizure freedom were collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of 500 patients with epilepsy, 163 (32.6%) patients (108 female and 55 male) reported suffering from headaches at least 1\u00a0day per month. MIG (without aura, with aura) and TTH were the most frequent headache type (MIG 33.1%, TTH 33.1%). Female epilepsy patients reported headaches significantly more often than male patients (<jats:italic>x<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20098.20, <jats:italic>p<\/jats:italic>\u2009=\u20090.0042). In contrast, the type of epilepsy did not significantly affect headache distribution. Of 163 patients with headache, 66 (40.5%) patients reported seizure-associated headache and AEDs were used by 157 patients. Of importance, patients with AED monotherapy suffered from MIG less often when compared to patients on polytherapy (<jats:italic>x<\/jats:italic><jats:sup>2<\/jats:sup>\u2009=\u20094.79, <jats:italic>p<\/jats:italic>\u2009=\u20090.028).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>MIG and TTH are the most common headache types in epilepsy patients and headache is more frequent among female epilepsy patients. Monotherapy in AEDs might have a beneficial effect on the frequency of headache compared to polytherapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40001-023-01023-8","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T06:03:04Z","timestamp":1674799384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Primary headache types in adult epilepsy patients"],"prefix":"10.1186","volume":"28","author":[{"given":"Katharina","family":"Schiller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Rauchenzauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamir","family":"Avidgor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Lorenzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Kaml","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Walser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Unterberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Broessner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Luef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"issue":"1","key":"1023_CR1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","volume":"15","author":"MR Keezer","year":"2016","unstructured":"Keezer MR, Sisodiya SM, Sander JW. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol. 2016;15(1):106\u201315.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1023_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.14581\/jer.17002","volume":"7","author":"DW Kim","year":"2017","unstructured":"Kim DW, Lee SK. Headache and epilepsy. J Epilepsy Res. 2017;7(1):7\u201315.","journal-title":"J Epilepsy Res"},{"issue":"3","key":"1023_CR3","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.yebeh.2012.09.025","volume":"26","author":"L Papetti","year":"2013","unstructured":"Papetti L, Nicita F, Parisi P, Spalice A, Villa MP, Kasteleijn-Nolst Trenite DG. \u201cHeadache and epilepsy\u201d\u2013how are they connected? Epilepsy Behav. 2013;26(3):386\u201393.","journal-title":"Epilepsy Behav"},{"key":"1023_CR4","unstructured":"Headache Classification Subcommittee of the International Headache S. The international classification of headache disorders: 2nd edition. Cephalalgia 2004; 24(Suppl 1):9\u2013160."},{"key":"1023_CR5","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache S. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013; 33(9):629\u2013808.","DOI":"10.1177\/0333102413485658"},{"issue":"11","key":"1023_CR6","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1212\/WNL.44.11.2105","volume":"44","author":"R Ottman","year":"1994","unstructured":"Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology. 1994;44(11):2105\u201310.","journal-title":"Neurology"},{"issue":"Suppl 2","key":"1023_CR7","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.yebeh.2003.07.003","volume":"4","author":"ME Bigal","year":"2003","unstructured":"Bigal ME, Lipton RB, Cohen J, Silberstein SD. Epilepsy and migraine. Epilepsy Behav. 2003;4(Suppl 2):S13-24.","journal-title":"Epilepsy Behav"},{"issue":"2","key":"1023_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3349\/ymj.2010.51.2.219","volume":"51","author":"Group HS","year":"2010","unstructured":"Group HS. Multi-center study on migraine and seizure-related headache in patients with epilepsy. Yonsei Med J. 2010;51(2):219\u201324.","journal-title":"Yonsei Med J"},{"issue":"1","key":"1023_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s10194-020-1074-0","volume":"21","author":"B Duko","year":"2020","unstructured":"Duko B, Ayalew M, Toma A. The epidemiology of headaches among patients with epilepsy: a systematic review and meta-analysis. J Headache Pain. 2020;21(1):3.","journal-title":"J Headache Pain"},{"issue":"10","key":"1023_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1046\/j.1526-4610.2001.01190.x","volume":"41","author":"JR Storey","year":"2001","unstructured":"Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache. 2001;41(10):968\u201375.","journal-title":"Headache"},{"issue":"8","key":"1023_CR11","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/jama.291.8.965","volume":"291","author":"JL Brandes","year":"2004","unstructured":"Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J, Neto W, Schwabe S, Jacobs D, Group M-S. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965\u201373.","journal-title":"JAMA"},{"issue":"2","key":"1023_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clinthera.2005.02.013","volume":"27","author":"SD Silberstein","year":"2005","unstructured":"Silberstein SD, Ben-Menachem E, Shank RP, Wiegand F. Topiramate monotherapy in epilepsy and migraine prevention. Clin Ther. 2005;27(2):154\u201365.","journal-title":"Clin Ther"},{"issue":"6","key":"1023_CR13","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10194-009-0164-9","volume":"10","author":"L Ruiz","year":"2009","unstructured":"Ruiz L, Ferrandi D. Topiramate in migraine progression. J Headache Pain. 2009;10(6):419\u201322.","journal-title":"J Headache Pain"},{"issue":"8","key":"1023_CR14","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00415-004-0464-6","volume":"251","author":"HC Diener","year":"2004","unstructured":"Diener HC, Tfelt-Hansen P, Dahlof C, Lainez MJ, Sandrini G, Wang SJ, Neto W, Vijapurkar U, Doyle A, Jacobs D, et al. Topiramate in migraine prophylaxis\u2013results from a placebo-controlled trial with propranolol as an active control. J Neurol. 2004;251(8):943\u201350.","journal-title":"J Neurol"},{"issue":"4","key":"1023_CR15","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0404.1988.tb03667.x","volume":"78","author":"KV Sorensen","year":"1988","unstructured":"Sorensen KV. Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand. 1988;78(4):346\u20138.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"1023_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1468-2982.1992.1202081.x","volume":"12","author":"R Hering","year":"1992","unstructured":"Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia. 1992;12(2):81\u20134.","journal-title":"Cephalalgia"},{"issue":"11","key":"1023_CR17","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1212\/WNL.58.11.1652","volume":"58","author":"FG Freitag","year":"2002","unstructured":"Freitag FG, Collins SD, Carlson HA, Goldstein J, Saper J, Silberstein S, Mathew N, Winner PK, Deaton R, Sommerville K, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58(11):1652\u20139.","journal-title":"Neurology"},{"issue":"10","key":"1023_CR18","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1468-2982.2006.01193.x","volume":"26","author":"C Lampl","year":"2006","unstructured":"Lampl C, Marecek S, May A, Bendtsen L. A prospective, open-label, long-term study of the efficacy and tolerability of topiramate in the prophylaxis of chronic tension-type headache. Cephalalgia. 2006;26(10):1203\u20138.","journal-title":"Cephalalgia"},{"key":"1023_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1129-2377-15-31","volume":"15","author":"TJ Steiner","year":"2014","unstructured":"Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lanteri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Barre J, et al. The impact of headache in Europe: principal results of the Eurolight project. J Headache Pain. 2014;15:31.","journal-title":"J Headache Pain"},{"issue":"Suppl 1","key":"1023_CR20","first-page":"S3","volume":"21","author":"DY Wei","year":"2018","unstructured":"Wei DY, Yuan Ong JJ, Goadsby PJ. Cluster headache: epidemiology, pathophysiology, clinical features, and diagnosis. Ann Indian Acad Neurol. 2018;21(Suppl 1):S3\u20138.","journal-title":"Ann Indian Acad Neurol"},{"issue":"8","key":"1023_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/BF02334974","volume":"13","author":"G Dalla Volta","year":"1992","unstructured":"Dalla Volta G, Di Monda V, Bariselli M, Vignolo LA. Headache and epilepsy: a case report of the unusual association of cluster headache and epilepsy. Ital J Neurol Sci. 1992;13(8):699.","journal-title":"Ital J Neurol Sci"},{"issue":"4","key":"1023_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"IE Scheffer","year":"2017","unstructured":"Scheffer IE, Berkovic S, Capovilla G, Connolly MB, French J, Guilhoto L, Hirsch E, Jain S, Mathern GW, Mosh\u00e9 SL, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4):512\u201321.","journal-title":"Epilepsia"},{"issue":"4","key":"1023_CR23","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1526-4610.2007.00758.x","volume":"47","author":"G Fritsche","year":"2007","unstructured":"Fritsche G, Hueppe M, Kukava M, Dzagnidze A, Schuerks M, Yoon MS, Diener HC, Katsarava Z. Validation of a german language questionnaire for screening for migraine, tension-type headache, and trigeminal autonomic cephalgias. Headache. 2007;47(4):546\u201351.","journal-title":"Headache"},{"key":"1023_CR24","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia 2018; 38(1):1\u2013211.","DOI":"10.1177\/0333102417738202"},{"issue":"3","key":"1023_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s10072-017-3232-y","volume":"39","author":"M Dedei Daryan","year":"2018","unstructured":"Dedei Daryan M, G\u00fcveli BT, Baslo SA, Mulhan K, Sar\u0131 H, Bal\u00e7\u0131k ZE, Atakl\u0131 D. Prevalence and clinical characteristics of headache in juvenile myoclonic epilepsy: experience from a tertiary epilepsy center. Neurol Sci. 2018;39(3):519\u201325.","journal-title":"Neurol Sci"},{"issue":"4","key":"1023_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/S1474-4422(08)70062-0","volume":"7","author":"R Jensen","year":"2008","unstructured":"Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol. 2008;7(4):354\u201361.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1023_CR27","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.ncl.2019.07.001","volume":"37","author":"MJ Burish","year":"2019","unstructured":"Burish MJ, Rozen TD. Trigeminal autonomic cephalalgias. Neurol Clin. 2019;37(4):847\u201369.","journal-title":"Neurol Clin"},{"issue":"3","key":"1023_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/2049463712456355","volume":"6","author":"R Benoliel","year":"2012","unstructured":"Benoliel R. Trigeminal autonomic cephalgias. Br J Pain. 2012;6(3):106\u201323.","journal-title":"Br J Pain"},{"issue":"27","key":"1023_CR29","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1523\/JNEUROSCI.0283-20.2020","volume":"40","author":"A Melo-Carrillo","year":"2020","unstructured":"Melo-Carrillo A, Schain AJ, Strassman AM, Burstein R. Activation of peripheral and central trigeminovascular neurons by seizure: implications for ictal and postictal headache. J Neurosci. 2020;40(27):5314\u201326.","journal-title":"J Neurosci"},{"issue":"4","key":"1023_CR30","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1468-1331.2006.01184.x","volume":"13","author":"LJ Stovner","year":"2006","unstructured":"Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol. 2006;13(4):333\u201345.","journal-title":"Eur J Neurol"},{"issue":"4","key":"1023_CR31","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1017\/S0317167100034892","volume":"25","author":"A Guberman","year":"1998","unstructured":"Guberman A. Monotherapy or polytherapy for epilepsy? Can J Neurol Sci. 1998;25(4):S3-8.","journal-title":"Can J Neurol Sci"},{"issue":"8","key":"1023_CR32","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.seizure.2012.06.013","volume":"21","author":"T Andrew","year":"2012","unstructured":"Andrew T, Milinis K, Baker G, Wieshmann U. Self reported adverse effects of mono and polytherapy for epilepsy. Seizure. 2012;21(8):610\u20133.","journal-title":"Seizure"},{"issue":"3","key":"1023_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1526-4610.2004.04053.x","volume":"44","author":"GS Miller","year":"2004","unstructured":"Miller GS. Efficacy and safety of levetiracetam in pediatric migraine. Headache. 2004;44(3):238\u201343.","journal-title":"Headache"},{"issue":"6","key":"1023_CR34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/01.WNF.0000236766.08409.03","volume":"29","author":"F Brighina","year":"2006","unstructured":"Brighina F, Palermo A, Aloisio A, Francolini M, Giglia G, Fierro B. Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study. Clin Neuropharmacol. 2006;29(6):338\u201342.","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"1023_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/187152411794961086","volume":"11","author":"V Pizza","year":"2011","unstructured":"Pizza V, Busillo V, Agresta A, Bisogno A, Capasso A. Elderly patients with migraine: an open-label study on prophylaxis therapy with levetiracetam. Cent Nerv Syst Agents Med Chem. 2011;11(1):31\u20134.","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"9","key":"1023_CR36","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1046\/j.1528-1157.2001.37500.x","volume":"42","author":"T Leniger","year":"2001","unstructured":"Leniger T, Isbruch K, von den Driesch S, Diener HC, Hufnagel A. Seizure-associated headache in epilepsy. Epilepsia. 2001;42(9):1176\u20139.","journal-title":"Epilepsia"},{"issue":"7","key":"1023_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1046\/j.1526-4610.2002.02154.x","volume":"42","author":"S Forderreuther","year":"2002","unstructured":"Forderreuther S, Henkel A, Noachtar S, Straube A. Headache associated with epileptic seizures: epidemiology and clinical characteristics. Headache. 2002;42(7):649\u201355.","journal-title":"Headache"},{"issue":"1","key":"1023_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/j.1468-2982.2004.00628.x","volume":"24","author":"M Ito","year":"2004","unstructured":"Ito M, Adachi N, Nakamura F, Koyama T, Okamura T, Kato M, Kanemoto K, Nakano T, Matsuura M, Hara S. Characteristics of postictal headache in patients with partial epilepsy. Cephalalgia. 2004;24(1):23\u20138.","journal-title":"Cephalalgia"},{"issue":"8","key":"1023_CR39","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1111\/j.1528-1167.2005.64804.x","volume":"46","author":"AE Yankovsky","year":"2005","unstructured":"Yankovsky AE, Andermann F, Bernasconi A. Characteristics of headache associated with intractable partial epilepsy. Epilepsia. 2005;46(8):1241\u20135.","journal-title":"Epilepsia"},{"key":"1023_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.seizure.2020.08.001","volume":"81","author":"F Caprara","year":"2020","unstructured":"Caprara F, Let\u00edcia A, Rissardo JP, Leite MTB, Silveira JOF, Jauris PGM, Arend J, Kegler A, Royes F, Fernando L, et al. Characteristics of post-ictal headaches in patients with epilepsy: a longitudinal study. Seizure. 2020;81:244\u20139.","journal-title":"Seizure"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01023-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-023-01023-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-023-01023-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T06:07:46Z","timestamp":1674799666000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-023-01023-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1023"],"URL":"https:\/\/doi.org\/10.1186\/s40001-023-01023-8","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"assertion":[{"value":"6 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was obtained from the ethics committee of University of Innsbruck (AN4469 304\/4.18). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}